The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus.

September 25, 2015

  • Clinical Trial Information

    Trial Contact: Noel, Henry

    Trial Phone: 321.841.3686

  • Age Group: Adult

    Phase: Drug: Phase III

    Principal Investigator: Deepak Pathe Vivek, MD

    Sub Investigators: Mark A. Steiner, MD;

    IRB No: 14.138.12

    Secondary Protocol No: D513BC00001

    Applicable Disease Sites: Diabetes Mellitus, Type 2